SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (5972)11/18/1998 10:33:00 AM
From: David Cathcart  Read Replies (1) of 9719
 
Good point Rick. I did not look for the spike to happen when it did and I don't look for another spike to happen now. Chances are we will not see that kind of drastic movement again with MOGN, either up or down. With future up-ticks, there will be a firmer foundation under the floor of the price. Increased revenue, greater acceptance of Salagen in the Sjogren's market, profitability and MGI 114 progress in the phase II trials are all reasons for the strengthened foundation. There may be more reasons in the near future.

The one caveat is that at some point in the future we could the kind of news that confirms the true value of MGI 114. With that news the stock will move, either up or down, and stay there. As you know, being a dyed-in-the-wool MOGN fan, I'm betting on the high side. As usual, thanks for your objective and sobering thoughts.

David
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext